Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rank in Stocks #42
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Share Price
$150.85
Market Cap
$372.57B
Change (1 day)
11.34%
Change (1 year)
77.62%
Country
US
Trade Merck & Co., Inc. (MRK)

Category

Earnings for Merck & Co., Inc. (MRK)
Earnings in Jun 2026 TTM: $5.95B
According to Merck & Co., Inc. latest financial reports the company's current earnings are $5.95B. In 2024 the company made an earning of $19.94B, an increase over its 2023 earnings that were of $1.89B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Merck & Co., Inc. from 2000 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $5.95B -71.77%
2025 $21.07B 5.67%
2024 $19.94B 955.37%
2023 $1.89B -88.51%
2022 $16.44B 18.48%
2021 $13.88B 136.72%
2020 $5.86B -18.24%
2019 $7.17B -17.58%
2018 $8.70B 33.43%
2017 $6.52B 39.97%
2016 $4.66B -13.74%
2015 $5.40B -68.75%
2014 $17.28B 211.69%
2013 $5.55B -36.55%
2012 $8.74B 19.16%
2011 $7.33B 343.68%
2010 $1.65B -89.19%
2009 $15.29B 53.96%
2008 $9.93B 194.63%
2007 $3.37B -45.82%
2006 $6.22B -15.51%
2005 $7.36B -7.98%
2004 $8.00B -11.59%
2003 $9.05B -6.22%
2002 $9.65B -2.98%
2001 $9.95B 1.26%
2000 $9.82B 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$33.59B 464.80%
US
$25.20B 323.60%
US
$8.70B 46.25%
US
$21.39B 259.59%
CH
$16.38B 175.36%
CH